Grant brings nearly 40 years of agricultural and corporate leadership, including as Chairman, President, and Chief Executive Officer of the former Monsanto Company, a global provider of technology-based solutions and agricultural products. During his 15 years at the helm, Monsanto tripled sales to $14 billion and its...
Read More
Invaio Sciences, Inc. today announced the closing of a Series C financing round totaling $88.9 million. Joining founder and principal backer Flagship Pioneering is Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments, and others. With this financing, Invaio has raised more than $142 million since its founding in...
Read More
Invaio Sciences announced today an agreement with the world-renowned Fundecitrus, Fund for Citrus Protection, located in Araraquara, Brazil. The agreement focuses on the collaboration to evaluate the use of a novel natural peptide to control the devastating disease Citrus Greening (HLB) in Brazilian citrus...
Read More
Invaio Sciences, Inc. announced today the appointment of Peleg Chevion as President and Chief Commercial Officer. Chevion, who joined the company in late 2020, will focus on accelerating the commercial activities of the company....
Read More
Invaio Sciences, Inc. announces today the appointment of new academic leaders as members to its Scientific Advisory Board (SAB). ...
Read More
Invaio Sciences, Inc. announces today the appointment of three new industry leading members to its Board of Directors. Dr. Pietro Antonio Tataranni is Chief Medical Officer at PepsiCo, Ena Cratsenburg is the Chief Business Officer at Ginkgo Bioworks, and Dr. Iya Khalil is Global...
Read More